Sato A, Zakarija M, McKenzie J M
Endocr Res Commun. 1978;5(4):259-69. doi: 10.1080/07435807809061091.
The influence of serum IgG from normal and Graves' disease subjects on the binding of 125I-thyrotropin to isolated thyroid membranes was studied. IgG from either source inhibited binding in a concentration -dependent fashion. Human membranes were more sensitive to the human IgG than were bovine thyroid membranes and, when membranes were purified by discontinuous sucrose gradient centrifugation, they were more sensitive than were those less-purified, obtained by differential centrifugation. Using a Dixon plot, inhibition by normal IgG showed non-competitive kinetics. Fab fragments were more effective, on an equimolar basis, than was intact normal IgG, but were less potent when Graves' disease IgG was the parent molecule; this difference implies distinct modes of inhibition of thyrotropin-binding. The degree of inhibition by normal IgG was variable so that multiple control preparations are required to assess the additional effect characteristic of IgG from the subject with Graves' disease.
研究了正常人和格雷夫斯病患者血清IgG对125I-促甲状腺激素与分离的甲状腺膜结合的影响。来自任何一种来源的IgG均以浓度依赖性方式抑制结合。人膜对人IgG的敏感性高于牛甲状腺膜,并且当通过不连续蔗糖梯度离心法纯化膜时,它们比通过差速离心法获得的纯化程度较低的膜更敏感。使用狄克逊图,正常IgG的抑制显示非竞争性动力学。在等摩尔基础上,Fab片段比完整的正常IgG更有效,但当格雷夫斯病IgG作为亲本分子时效力较低;这种差异意味着对促甲状腺激素结合的抑制模式不同。正常IgG的抑制程度是可变的,因此需要多个对照制剂来评估格雷夫斯病患者IgG的额外效应特征。